BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 18286688)

  • 1. Predictive value of Ki67 and p53 in locally advanced rectal cancer: correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapy.
    Jakob C; Liersch T; Meyer W; Becker H; Baretton GB; Aust DE
    World J Gastroenterol; 2008 Feb; 14(7):1060-6. PubMed ID: 18286688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymidylate synthase genotype-directed neoadjuvant chemoradiation for patients with rectal adenocarcinoma.
    Tan BR; Thomas F; Myerson RJ; Zehnbauer B; Trinkaus K; Malyapa RS; Mutch MG; Abbey EE; Alyasiry A; Fleshman JW; McLeod HL
    J Clin Oncol; 2011 Mar; 29(7):875-83. PubMed ID: 21205745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Value of Tumor-Infiltrating Lymphocytes and Ki-67 for Pathological Response to Total Neoadjuvant Therapy in Rectal Cancer.
    Mohammed A; Bakry A; Gharieb S; Hanna A; Obaya A; Abdelhady W; Metwalli A
    J Gastrointest Cancer; 2024 Jun; 55(2):869-876. PubMed ID: 38358621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation-induced changes in gene expression in rectal cancer specimens.
    Hillson LVS; McCulloch AK; Edwards J; Dunne PD; O'Cathail SM; Roxburgh CS
    Clin Transl Oncol; 2024 Jun; 26(6):1419-1428. PubMed ID: 38243085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular prognostic factors in colorectal cancer: 5-year follow-up.
    Ciobanu AE; Pîrvu DC; Mărginean CM; Dijmărescu AL; Muñoz-Groza AE; Meşină C; Bălşeanu TA; Băleanu VD; Ţenea-Cojan TŞ; Ciobanu D
    Rom J Morphol Embryol; 2023; 64(1):65-71. PubMed ID: 37128793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Panel of Tumor Biomarkers to Predict Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.
    Dalle Fratte C; Mezzalira S; Polesel J; De Mattia E; Palumbo A; Buonadonna A; Palazzari E; De Paoli A; Belluco C; Canzonieri V; Toffoli G; Cecchin E
    Oncol Res; 2022 Jan; 28(9):847-855. PubMed ID: 34108073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Response to Neoadjuvant Therapy in Colorectal Cancer Patients the Role of Messenger-and Micro-RNA Profiling.
    Izzotti A; Ceccaroli C; Geretto M; Ruggieri FG; Schenone S; Di Maria E
    Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32580435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized Medicine-Current and Emerging Predictive and Prognostic Biomarkers in Colorectal Cancer.
    Koulis C; Yap R; Engel R; Jardé T; Wilkins S; Solon G; Shapiro JD; Abud H; McMurrick P
    Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32231042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Molecular Pretreated Tumor Profiles as Predictive Biomarkers of Therapeutic Response and Survival Outcomes after Neoadjuvant Therapy for Rectal Cancer in Moroccan Population.
    El Otmani I; El Agy F; El Baradai S; Bouguenouch L; Lahmidani N; El Abkari M; Benajah DA; Toughrai I; El Bouhaddouti H; Mouaqit O; Ibn Majdoub Hassani K; Mazaz K; Benjelloun EB; Ousadden A; El Rhazi K; Bouhafa T; Benbrahim Z; Ouldim K; Ibrahimi SA; Ait Taleb K; Chbani L
    Dis Markers; 2020; 2020():8459303. PubMed ID: 31998419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Heterogeneity as a Predictor of Response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer.
    Greenbaum A; Martin DR; Bocklage T; Lee JH; Ness SA; Rajput A
    Clin Colorectal Cancer; 2019 Jun; 18(2):102-109. PubMed ID: 30935775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Biology: Are We Getting Any Closer to Providing Clinically Useful Information?
    Karagkounis G; Kalady MF
    Clin Colon Rectal Surg; 2017 Nov; 30(5):415-422. PubMed ID: 29184477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Impact of mRNA Expression Levels of HER1-4 (ERBB1-4) in Patients with Locally Advanced Rectal Cancer.
    Kripp M; Merx K; Wirtz RM; Gaiser T; Eidt S; Schwaab J; Post S; Wenz F; Hochhaus A; Hofheinz RD; Erben P
    Gastroenterol Res Pract; 2016; 2016():3481578. PubMed ID: 27610130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo antitumor effects of the Egyptian scorpion Androctonus amoreuxi venom in an Ehrlich ascites tumor model.
    Salem ML; Shoukry NM; Teleb WK; Abdel-Daim MM; Abdel-Rahman MA
    Springerplus; 2016; 5():570. PubMed ID: 27247867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can an IL13 -1112 C/T (rs1800925) polymorphism predict responsiveness to neoadjuvant chemoradiotherapy and survival of Chinese Han patients with locally advanced rectal cancer?
    Xiao L; Yu X; Zhang R; Chang H; Xi S; Xiao W; Zeng Z; Zhang H; Xu R; Gao Y
    Oncotarget; 2016 Jun; 7(23):34149-57. PubMed ID: 27167201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective feasibility study to evaluate neoadjuvant-synchronous S-1 with radiotherapy for locally advanced rectal cancer: A multicentre phase II trial.
    Inomata M; Akagi T; Nakajima K; Etoh T; Tahara K; Matsumoto T; Ogawa T; Fujii K; Shiromizu A; Kitano S
    Mol Clin Oncol; 2016 Apr; 4(4):510-514. PubMed ID: 27073652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Perspectives on Predictive Biomarkers of Tumor Response and Their Clinical Application in Preoperative Chemoradiation Therapy for Rectal Cancer.
    Kim NK; Hur H
    Yonsei Med J; 2015 Nov; 56(6):1461-77. PubMed ID: 26446626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YKL-40/c-Met expression in rectal cancer biopsies predicts tumor regression following neoadjuvant chemoradiotherapy: a multi-institutional study.
    Senetta R; Duregon E; Sonetto C; Spadi R; Mistrangelo M; Racca P; Chiusa L; Munoz FH; Ricardi U; Arezzo A; Cassenti A; Castellano I; Papotti M; Morino M; Risio M; Cassoni P
    PLoS One; 2015; 10(4):e0123759. PubMed ID: 25875173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive markers of chemoradiotherapy for rectal cancer: comparison of biopsy specimens taken before and about 1 week after the start of chemoradiotherapy.
    Suzuki T; Sadahiro S; Tanaka A; Okada K; Saito G; Kamijo A; Akiba T; Kawada S
    Int J Clin Oncol; 2015 Dec; 20(6):1130-9. PubMed ID: 25833701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical detection of p53 expression in patients with preoperative chemoradiation for rectal cancer: association with prognosis.
    Huh JW; Lee WY; Kim SH; Park YA; Cho YB; Yun SH; Kim HC; Park HC; Choi DH; Park JO; Park YS; Chun HK
    Yonsei Med J; 2015 Jan; 56(1):82-8. PubMed ID: 25510750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p27 expression in post-treatment rectal cancer: a potential novel approach for predicting residual nodal disease.
    Leibold T; Hui VW; Shia J; Ruby JA; Riedel ER; Guillem JG
    Am J Surg; 2014 Aug; 208(2):228-34. PubMed ID: 24814310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.